WILMINGTON, Del., April 17, 2017 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:
Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States
District Court for the District of Delaware on behalf of holders of GenVec, Inc. (“GenVec”) (NASDAQ:GNVC) common stock in
connection with the proposed acquisition of GenVec by Intrexon Corporation and Intrexon GV Holding, Inc. (collectively, “Intrexon”)
announced on January 24, 2017 (the “Complaint”). The Complaint, which alleges violations of the Securities Exchange Act of
1934 against GenVec, its Board of Directors (the “Board”), and Intrexon, is captioned Parshall v. GenVec, Inc., Case No.
1:17-cv-00338-GMS (D. Del.).
If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact
plaintiff’s counsel, Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at
(888) 969-4242; by e-mail at info@rl-legal.com; or at http://rigrodskylong.com/contact-us/.
On January 24, 2017, GenVec entered into an agreement and plan of merger (the “Merger Agreement”) with Intrexon. Pursuant
to the Merger Agreement, GenVec shareholders will receive 0.297 shares of Intrexon common stock, plus one contingent payment right
(the “Proposed Transaction”).
Among other things, the Complaint alleges that, in an attempt to secure shareholder support for the Proposed Transaction,
defendants issued materially incomplete disclosures in a registration statement (the “Registration Statement”) filed with the
United States Securities and Exchange Commission on March 17, 2017. The Registration Statement, which recommends that GenVec
stockholders vote in favor of the Proposed Transaction, omits material information necessary to enable shareholders to make an
informed decision as to how to vote on the Proposed Transaction, including material information with respect to GenVec’s financial
projections, the analyses performed by GenVec’s financial advisor, and potential conflicts of interest. The Complaint seeks
injunctive and equitable relief and damages on behalf of holders of GenVec common stock.
If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2017. A lead plaintiff is a
representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class
may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent
class member.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York,
regularly prosecutes securities fraud, shareholder corporate, and shareholder derivative litigation on behalf of
shareholders in state and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Seth D. Rigrodsky Gina M. Serra (888) 969-4242 (302) 295-5310 Fax: (302) 654-7530 info@rl-legal.com http://www.rigrodskylong.com